Anti-inflammatory add-on treatment after certain aortic conditions
Part of Heart & circulation clinical trials.
This study tests whether an “add-on” anti-inflammatory approach can help after surgery for certain problems affecting the aorta (the body’s main artery) soon after symptoms begin. It may be designed to reduce inflammation-related complications in people who are treated quickly and can join follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a confirmed aortic condition such as aortic dissection, penetrating aortic ulcer, or intramural hematoma
- Your symptoms began within 14 days after surgery
- You received medical therapy or an open, endovascular, or hybrid repair for the aortic condition
- You agree (or your guardian agrees) to join the study and follow the visit schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new way to help doctors quickly identify serious aortic conditions (problems with the main artery from the heart) in people who come to the emergency room with chest, back, or belly pain. It aims to improve early diagnosis and treatment.
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
This study is testing whether a simple blood test combined with a risk score can help doctors safely rule out a serious tear in the aorta (the main artery) in people who come to the ER with symptoms like chest or back pain. If the test works, it can help avoid extra scans and get you the right care faster.
This trial tests whether using artificial intelligence to guide treatment choices can improve recovery in people with a sudden tear in the main artery (aortic dissection). All participants will receive emergency surgery, but the AI may help doctors tailor the approach to each person's condition, potentially reducing complications.
This trial tests whether two anti-inflammatory drugs, ulinastatin and thymosin α1, can help protect your immune system and organs after emergency surgery for a torn aorta (aortic dissection). If you qualify and take part, you may receive these medications in addition to standard care.
This trial compares two different surgical approaches to repair a life-threatening tear or bulge in the large artery that carries blood from the heart (aorta). The study will help doctors determine which technique is safer and works better for patients needing this complex surgery.
Hear when a new Acute Aortic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.